Sowell Financial Services’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-76
Closed -$1K 900
2021
Q1
$1K Sell
76
-1,193
-94% -$20.3K ﹤0.01% 2911
2020
Q4
$22K Buy
1,269
+364
+40% +$6.48K ﹤0.01% 1692
2020
Q3
$17K Buy
905
+480
+113% +$8.93K ﹤0.01% 1621
2020
Q2
$8K Hold
425
﹤0.01% 1755
2020
Q1
$7K Buy
+425
New +$7.85K ﹤0.01% 1703

Other funds holding CHRS

Sowell Financial Services's CHRS Position: Q2 2021 in Review

Sowell Financial Services sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 76 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in CHRS in Q1 2020 and held it in 5 quarters. The position peaked at $22K in Q4 2020. 189 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.

  • Sowell Financial Services reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 76 Coherus Oncology shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Coherus Oncology in Q1 2020 and held it in 5 quarters.
  • Sowell Financial Services's Coherus Oncology position peaked at $22K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.